PTN
Palatin Technologies Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
palatin technologies, inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the united states. the company's lead product is vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. it is also developing oral pl8177, a selective melanocortin receptor (mcr) 1 agonist peptide that has completed phase i clinical trial for the treatment of inflammatory bowel diseases; and systemic pl8177, which has completed phase i clinical trial for treating non-infectious uveitis and covid-19. in addition, the company engages in the development of pl9643, a peptide melanocortin agonist active at multiple mcrs, including mc1r and mc5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. further, it is developing pl3994, a natriuretic peptide receptor (npr)-a agonist and sy
Market Cap: 30 Million
Primary Exchange: NYSE MKT LLC
Website: https://www.palatin.com/
Shares Outstanding: 16.1 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.2722536855162496
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1015 trading days
From: 2014-03-21 To: 2018-04-11
Lowest Point:
AMAG: Great Value Behind That Not-So-Rosy Growth
via: SeekingAlpha at 2019-06-11 07:45:17:000
Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...
AMAG: Great Value Behind That Not-So-Rosy Growth
via: SeekingAlpha at 2019-06-11 07:45:17:000
Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...
AMAG: Great Value Behind That Not-So-Rosy Growth
via: SeekingAlpha at 2019-06-11 07:45:17:000
Introduction: AMAG Pharmaceuticals ( AMAG ) is a specialty pharmaceuticals company with an emphasis on Women's Health and treatment of Iron Deficiency Anemia. The company's stock has been punished over the past quarter due to the presence of generics taking market share from its key produ… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|